Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL2000216	注射用HR18034	ropivacaine	Lyophilized	Chemical Drugs(2.1;2.2)	New Drug Application	2020-05-22	江苏恒瑞医药股份有限公司	Jiangsu Hengrui Pharmaceuticals Co Ltd	In Review	2020-05-20	view
CXHB2400047	注射用HR18034	ropivacaine	Lyophilized	Chemical Drugs(2.1;2.2)	Supplementary Application	2024-02-19		Shanghai Hengrui Pharmaceutical Co Ltd			view
CXHB2200040	注射用HR18034	ropivacaine	Lyophilized	Chemical Drugs(2.1)	Supplementary Application	2022-03-17		Shanghai Hengrui Pharmaceutical Co Ltd			view
CXHL2200145	注射用HR18034	ropivacaine	Lyophilized	Chemical Drugs(2.1;2.2)	New Drug Application	2022-03-07		Shanghai Hengrui Pharmaceutical Co Ltd			view
CXHL2101164	注射用HR18034	ropivacaine	Lyophilized	Chemical Drugs(2.1)	New Drug Application	2021-05-28		Shanghai Hengrui Pharmaceutical Co Ltd			view